MBO for Vickers Laboratories
Current members of management team buy firm from major shareholder
Three members of the company’s current management team – Steve Foster, operations director; Phil Constantine, operations manager; and Paul Bottomley, quality and supply chain manager – have acquired the business from the current majority shareholder, Julian Driver. They aim to grow the business by finding new product niches.
Driver has been involved with the firm since 1976 and now wants to take some time off to pursue other interests.
Since 2003 profit levels have increased by more than 20%. Current turnover is £2.25m.
The new management team emphasises that it is ‘business as usual but with some changes’ for the Pudsey based business, which employs 22 people.
All three participants in the MBO have been with the company for more than 20 years and have played a major part in its success.
Foster, the new managing director, joined Vickers in 1987 as a laboratory chemist. He then moved into products and services, launching the customer service team, before taking over operations in 2002.
Bottomley, sales director in the new team, joined Vickers in 1983 and progressed through operations and administration before becoming the company’s buyer and then supply chain manager. He has recently implemented a joint venture in Asia and has managed the quality system to achieve ISO 9001-2008.
Constantine, the new operations director, joined the company in 1981. Starting as a process operator, he became operations manager in 2007.
‘It is very exciting and fulfilling on a personal level to see the team I have worked with and mentored over many years become the new owners of the business,’ said Driver.
Vickers currently operates on four key areas: laboratory reagents; specialised monomers for use in the contact lens and medical industries; precision solutions and liquids for industry; and online monitoring for the water industry.
You may also like
Manufacturing
Pharmaceutical labelling in focus at Interpack 2026
Read moreWell prepared for new requirements. The upcoming reform of EU pharmaceutical legislation is expected to bring stricter requirements for traceability and labelling. The new 152E HC wrap-around labelling machine, developed specifically for contract packers, covers a wide product range with minimal change parts. Also on display: specialised labelling machines for automated product handling of small batches and high-speed labelling applications.
Trending Articles
You may also like
Manufacturing
Pharmaceutical labelling in focus at Interpack 2026
Well prepared for new requirements. The upcoming reform of EU pharmaceutical legislation is expected to bring stricter requirements for traceability and labelling. The new 152E HC wrap-around labelling machine, developed specifically for contract packers, covers a wide product range with minimal change parts. Also on display: specialised labelling machines for automated product handling of small batches and high-speed labelling applications.
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Research & Development
Applied Biopharm Consulting awarded Innovation funding to validate AI-powered AAV vector engineering platform
Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise Office Cork North & West to collaborate with an academic partner in validating its computational platform for adeno-associated virus vector optimisation through laboratory testing
Manufacturing
Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering